0,862  0,008  Antiinflammatory
0,731  0,005  Nitric oxide antagonist
0,680  0,007  Antiparasitic
0,669  0,004  Antihelmintic
0,613  0,013  CYP2C19 substrate
0,533  0,004  Abortion inducer
0,562  0,036  Transcription factor NF kappa B inhibitor
0,533  0,017  Cardiovascular analeptic
0,532  0,028  Cholesterol antagonist
0,558  0,058  Apoptosis agonist
0,483  0,004  Lipocortins synthesis antagonist
0,479  0,005  Sodium/bile acid cotransporter inhibitor
0,479  0,005  Pneumotoxic
0,481  0,022  NOS3 expression inhibitor
0,500  0,046  TNF expression inhibitor
0,455  0,019  UGT2B4 substrate
0,463  0,028  Hepatic disorders treatment
0,436  0,031  AR expression inhibitor
0,431  0,038  Antineoplastic (ovarian cancer)
0,463  0,076  Caspase 9 stimulant
0,423  0,044  Antiprotozoal (Plasmodium)
0,439  0,061  Antibacterial
0,403  0,028  Proliferative diseases treatment
0,428  0,056  Antipruritic, allergic
0,378  0,012  Prostate disorders treatment
0,398  0,040  Antiischemic
0,386  0,035  NOS2 expression inhibitor
0,389  0,041  Antineoplastic (pancreatic cancer)
0,339  0,007  UGT2B9 substrate
0,343  0,016  Antipruritic, non-allergic
0,337  0,018  Prostatic (benign) hyperplasia treatment
0,326  0,014  NOS3 expression enhancer
0,329  0,018  Antiacne
0,333  0,022  Hepatoprotectant
0,334  0,025  UGT1A4 substrate
0,351  0,045  Antineoplastic (cervical cancer)
0,388  0,083  Antineoplastic (breast cancer)
0,377  0,078  Antiprotozoal
0,345  0,051  CTGF expression inhibitor
0,296  0,007  Androgen antagonist
0,298  0,014  Antidiarrheal
0,323  0,039  Chemopreventive
0,308  0,025  UGT2B7 substrate
0,320  0,042  Vasodilator
0,330  0,063  Respiratory analeptic
0,314  0,048  Hypoglycemic
0,272  0,008  UGT2B10 substrate
0,309  0,050  Cytotoxic
0,292  0,034  UGT1A1 substrate
0,330  0,072  ICAM1 expression inhibitor
0,291  0,037  UDP-glucuronosyltransferase substrate
0,249  0,006  Arachidonic acid antagonist
0,279  0,039  Anesthetic general
0,281  0,056  5 Hydroxytryptamine uptake stimulant
0,252  0,026  Lipid peroxidase inhibitor
0,235  0,014  Farnesoid X receptor antagonist
0,296  0,075  Metabolic disease treatment
0,301  0,080  Antifungal
0,290  0,072  CYP1A2 substrate
0,228  0,012  Choleretic
0,282  0,067  UGT1A9 substrate
0,243  0,029  UGT2B15 substrate
0,273  0,060  Angiogenesis stimulant
0,289  0,082  Analeptic
0,252  0,045  Antiviral (Influenza)
0,299  0,092  Calcium channel activator
0,255  0,051  Antihypotensive
0,243  0,043  Neurotrophic factor enhancer
0,308  0,110  Immunosuppressant
0,262  0,064  Sensitization
0,205  0,009  Pregnane X receptor agonist
0,267  0,072  Chemoprotective
0,211  0,017  Microtubule formation inhibitor
0,294  0,103  CYP3A4 substrate
0,223  0,033  Antiviral (Influenza A)
0,263  0,077  Antioxidant
0,239  0,057  RNA-directed DNA polymerase inhibitor
0,256  0,076  Antihypercholesterolemic
0,184  0,006  Anabolic
0,216  0,038  Contraceptive
0,214  0,036  Interferon gamma antagonist
0,241  0,066  UGT1A6 substrate
0,224  0,051  Myocardial ischemia treatment
0,179  0,007  UGT2B11 substrate
0,209  0,038  Phospholipase C inhibitor
0,187  0,016  Photosensitizer
0,258  0,093  Cardioprotectant
0,197  0,033  Antifungal enhancer
0,172  0,010  SULT1E1 substrate
0,240  0,084  Antineoplastic (renal cancer)
0,247  0,092  Antiosteoporotic
0,182  0,029  Antifungal (Cryptococcus)
0,180  0,033  Aldehyde dehydrogenase inhibitor
0,151  0,006  Anticholelithogenic
0,303  0,160  Cyclophilin D inhibitor
0,303  0,160  Antidiabetic
0,191  0,049  Antirickettsial
0,148  0,007  Glycine receptor agonist
0,251  0,113  Bone diseases treatment
0,161  0,026  Contraceptive female
0,139  0,005  Antimycoplasmal
0,245  0,112  Prostate cancer treatment
0,188  0,057  UGT1A3 substrate
0,139  0,008  Na+ K+ transporting ATPase inhibitor
0,148  0,024  CC chemokine 6 receptor antagonist
0,143  0,019  Thioredoxin inhibitor
0,170  0,047  CF transmembrane conductance regulator agonist
0,161  0,039  Cholesterol synthesis inhibitor
0,135  0,016  Interleukin 5 antagonist
0,191  0,071  VEGF expression inhibitor
0,126  0,010  Narcotic antagonist
0,125  0,009  Androgen agonist
0,177  0,065  Toxic, respiratory center
0,207  0,095  Antineoplastic (glioma)
0,127  0,015  Glycine receptor antagonist
0,187  0,076  Carcinogenic
0,240  0,131  Antineoplastic (lung cancer)
0,193  0,089  Antineoplastic (glioblastoma multiforme)
0,131  0,027  Actinic keratosis treatment
0,140  0,038  Constipation treatment
0,163  0,066  Melanin inhibitor
0,100  0,005  Lipocortins synthesis agonist
0,163  0,069  Antimutagenic
0,098  0,006  RNA-directed RNA polymerase stimulant
0,094  0,007  Postcoital contraceptive
0,123  0,038  Antineoplastic antibiotic
0,147  0,062  Neurotrophic factor
0,149  0,065  Adenylate cyclase stimulant
0,127  0,043  Estrogen antagonist
0,224  0,143  GST M1-1 substrate
0,093  0,013  SULT2A1 substrate
0,226  0,148  Interleukin 2 agonist
0,103  0,025  Estrogen receptor alpha antagonist
0,123  0,045  UGT2B1 substrate
0,137  0,060  Antihyperlipoproteinemic
0,085  0,009  Anesthetic inhalation
0,137  0,061  Antihemorrhagic
0,144  0,073  Hair growth stimulant
0,070  0,002  Excitatory amino acid transporter 1 inhibitor
0,187  0,121  Antineoplastic (liver cancer)
0,218  0,151  Antileukemic
0,140  0,074  Ca2+-transporting ATPase inhibitor
0,123  0,060  Alcohol dehydrogenase substrate
0,109  0,047  Estrogen receptor beta antagonist
0,093  0,032  CDC25A inhibitor
0,095  0,038  CYP2A6 inhibitor
0,122  0,069  Carcinogenic, group 3
0,107  0,056  Sulfotransferase substrate
0,126  0,077  Anesthetic
0,060  0,012  Parathyroid hormone antagonist
0,056  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,221  0,176  CYP2C9 substrate
0,153  0,108  Succinate dehydrogenase inhibitor
0,144  0,101  Antipruritic
0,056  0,013  Glucocorticoid antagonist
0,089  0,047  Antiprotozoal activity enhancer
0,050  0,008  Tubulin agonist
0,066  0,026  Protein 50S ribosomal subunit inhibitor
0,089  0,049  Inducible nitric-oxide synthase inhibitor
0,072  0,032  Aromatase inhibitor
0,163  0,123  Antiparkinsonian, rigidity relieving
0,063  0,024  Pregnane X receptor antagonist
0,169  0,135  Tumour necrosis factor alpha release inhibitor
0,050  0,017  Hypogonadism treatment
0,054  0,021  Opioid kappa receptor agonist
0,212  0,180  Stroke treatment
0,048  0,016  Farnesoid X receptor agonist
0,161  0,130  Aldehyde oxidase inhibitor
0,111  0,080  Growth stimulant
0,054  0,023  Microtubule stabilization
0,154  0,126  CYP2B6 inhibitor
0,059  0,033  Postmenopausal disorders treatment
0,180  0,154  DNA synthesis inhibitor
0,169  0,146  DNA damaging
0,158  0,136  Antiprotozoal (Leishmania)
0,043  0,022  5-Alpha-reductase inhibitor
0,196  0,175  Caspase 3 stimulant
0,162  0,142  Cytostatic
0,117  0,098  Antiparkinsonian, tremor relieving
0,178  0,161  Antidiabetic (type 2)
0,205  0,192  FMO1 substrate
0,030  0,017  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,028  0,017  Hedgehog signaling activator
0,059  0,048  Heme oxygenase stimulant
0,091  0,080  Expectorant
0,105  0,095  Alpha-N-acetylglucosaminidase inhibitor
0,079  0,069  Antiviral (Dengue virus)
0,166  0,156  Lipoprotein disorders treatment
0,088  0,079  Bile acid receptor antagonist
0,022  0,013  Corticosteroid-like
0,095  0,086  SULT1A1 substrate
0,195  0,186  Vasodilator, coronary
0,063  0,055  Hypercalcemia treatment
0,023  0,015  GRP78 expression inhibitor
0,093  0,086  Antiinfertility, female
0,022  0,016  Vitamin D receptor antagonist
0,159  0,153  VCAM1 expression inhibitor
0,019  0,014  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,044  0,040  Estrogen agonist
0,062  0,058  Premenstrual syndrome treatment
0,015  0,012  Thromboxane A2 agonist
0,042  0,039  Potassium channel Kv1.3 blocker
0,006  0,004  Transcortin receptor antagonist
0,032  0,030  HMG CoA reductase inhibitor
0,015  0,014  Vitamin D receptor agonist
0,062  0,061  Glutamate (mGluR6) antagonist
0,016  0,015  Telomerase stimulant

